NCT05977738View on ClinicalTrials.gov

Repurposed Drugs in Research for Cancer Clinical Trials- Pitavastatin

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 18, 2024

Primary Completion Date

July 19, 2024

Study Completion Date

July 19, 2024

Conditions
Glioblastoma Multiforme, AdultRecurrent Glioblastoma
Interventions
DRUG

Pitavastatin calcium

Daily Pitavastatin administration

Trial Locations (1)

3015 GE

Erasmus MC, Rotterdam

All Listed Sponsors
lead

C.Dirven

OTHER

NCT05977738 - Repurposed Drugs in Research for Cancer Clinical Trials- Pitavastatin | Biotech Hunter | Biotech Hunter